Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cipherome develops AI-driven bioinformatics platforms to enable precision medicine by integrating genomic data with patient demographics and medical history. Its flagship products—COMPASS and the Drug Safety Score algorithm—are designed to predict adverse drug reactions and optimize medication choices. The company has conducted multi-institutional clinical studies to validate its technology with leading academic centers such as Stanford University, Seoul National University Bundang Hospital, and Leiden University Medical Center. It has also launched commercial pilots targeting diverse populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cipherome.